Table 2.
Anthropometric, vital, and laboratory data at baseline and 1-year follow-up
|
Parameter |
Baseline |
1-year follow-up |
Change |
P-value1) |
|||
|---|---|---|---|---|---|---|---|
| n | mean ± SD | n | mean ± SD | n | mean ± SD | ||
| Body weight, kg |
491 |
62.2 ± 12.4 |
434 |
63.5 ± 11.8 |
434 |
1.3 ± 4.3 |
*** |
| BMI, kg/m2 |
490 |
23.9 ± 4.0 |
433 |
24.4 ± 3.7 |
433 |
0.5 ± 1.6 |
*** |
| HbA1c, % |
506 |
10.3 ± 2.0 |
482 |
7.5 ± 1.3 |
478 |
−2.7 ± 2.2 |
*** |
| FPG, mg/dL |
254 |
217.3 ± 80.8 |
137 |
139.0 ± 48.7 |
91 |
−79.0 ± 92.9 |
*** |
| PPG, mg/dL |
329 |
296.1 ± 96.0 |
380 |
178.2 ± 68.6 |
256 |
−115.9 ± 111.1 |
*** |
| Total cholesterol, mg/dL |
439 |
201.4 ± 43.6 |
309 |
187.7 ± 35.9 |
286 |
−12.6 ± 44.2 |
*** |
| LDL-cholesterol, mg/dL |
294 |
122.0 ± 34.0 |
383 |
110.5 ± 28.3 |
239 |
−11.0 ± 32.0 |
*** |
| HDL-cholesterol, mg/dL |
|
|
|
|
|
|
|
| Men |
277 |
50.0 ± 13.7 |
268 |
53.2 ± 15.2 |
234 |
3.1 ± 11.3 |
*** |
| Women |
163 |
56.8 ± 15.9 |
151 |
58.1 ± 15.7 |
135 |
2.3 ± 12.1 |
* |
| Triglycerides, mg/dL |
465 |
159.7 ± 132.0 |
447 |
138.0 ± 85.3 |
410 |
−19.7 ± 128.3 |
** |
| Creatinine, mg/dL |
404 |
0.76 ± 0.42 |
422 |
0.86 ± 0.58 |
334 |
0.11 ± 0.66 |
** |
| SBP, mmHg |
474 |
132.1 ± 18.5 |
466 |
132.8 ± 17.7 |
435 |
1.0 ± 20.6 |
N.S. |
| DBP, mmHg | 474 | 76.5 ± 11.7 | 466 | 74.5 ± 10.8 | 435 | −1.9 ± 12.4 | ** |
Abbreviations: BMI body mass index, DBP diastolic blood pressure, FPG fasting plasma glucose, Hb hemoglobin, HDL high-density lipoprotein, LDL low-density lipoprotein, PPG postprandial plasma glucose, SBP systolic blood pressure.
1)Paired t-test.
N.S. not statistically significant, *P < .05, **P < .01, ***P < .001.